A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study

A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study

Aim. To compare the kinetics of dissolution (in vitro) and some pharmacodynamic and pharmacokinetic parameters of branded generic preparations of acetylsalicylic acid (ASA) in buffered form in cardioprotective doses [ASA 75 mg+Mg(OH)2 15.2 mg], which differ in the composition of excipients, with a r...

Full description

Bibliographic Details
Main Authors: N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2020-07-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
antiplatelet therapy
acetylsalicylic acid
coronary heart disease
secondary prevention
laboratory efficacy
Online Access:https://www.rpcardio.com/jour/article/view/2215

Similar Items

Similar Items